Yali Cao

P.R. China, 
Nanchang, CN 
P.R. China, 
Nanchang, CN 
OverviewLocationsClinical Research

Overview

Yali Cao practices in Nanchang, China. Their top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Fibroadenoma, Breast Cancer in Men, and Mastectomy.

Their clinical research consists of co-authoring 33 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

P.R. China, Nanchang, 330025, China
Other Locations
Key Laboratory Of Marine Chemistry Theory And Technology, Qingdao, 266100, China
Beijing, China
Jining, China
P.R. China, Jining, 272100, China
Key Laboratory Of Cancer Prevention And Therapy, Key Laboratory Of Breast Cancer Prevention And Therapy, Tianjin, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
Enrollment Status: Unknown
Publish Date: April 19, 2017
Intervention Type: Drug
Study Drugs: 5-Fu/Epirubicin/CTX Following Docetaxel, Docetaxel/Capecitabine Followed by Capecitabine/Epirubicin/Cyclophosphamide
Study Phase: Phase 3

33 Total Publications

Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: A retrospective study.
Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: A retrospective study.
Journal: Oncology letters
Published: November 19, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cao's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile